Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial
Publication
, Conference
Butler, J; Green, JB; Rosenstock, J
Published in: DIABETOLOGIA
September 2022
Duke Scholars
Published In
DIABETOLOGIA
EISSN
1432-0428
ISSN
0012-186X
Publication Date
September 2022
Volume
65
Issue
SUPPL 1
Start / End Page
S285 / S286
Related Subject Headings
- Endocrinology & Metabolism
- 4206 Public health
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Butler, J., Green, J. B., & Rosenstock, J. (2022). Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial. In DIABETOLOGIA (Vol. 65, pp. S285–S286).
Butler, J., J. B. Green, and J. Rosenstock. “Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial.” In DIABETOLOGIA, 65:S285–86, 2022.
Butler J, Green JB, Rosenstock J. Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial. In: DIABETOLOGIA. 2022. p. S285–6.
Butler, J., et al. “Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial.” DIABETOLOGIA, vol. 65, no. SUPPL 1, 2022, pp. S285–86.
Butler J, Green JB, Rosenstock J. Impact of empagliflozin on insulin use in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes: sub-analysis from EMPEROR-Preserved trial. DIABETOLOGIA. 2022. p. S285–S286.
Published In
DIABETOLOGIA
EISSN
1432-0428
ISSN
0012-186X
Publication Date
September 2022
Volume
65
Issue
SUPPL 1
Start / End Page
S285 / S286
Related Subject Headings
- Endocrinology & Metabolism
- 4206 Public health
- 3202 Clinical sciences